Aurobindo Pharma to acquire Portugal’s Generis Farmaceutica SA for 135 million euros



corporatevaluations.in : news

Aurobindo Pharma to acquire Portugal’s Generis Farmaceutica SA for 135 million euros


Date: 8-January-2017

Aurobindo Pharma has inked a binding agreement through its wholly-owned subsidiary Agile Pharma BV Netherlands to acquire Generis Farmaceutica for a total consideration of 135 million euros (around Rs 969 crore).Generis produces and sells pharma products in Portugal.The acquisition deal includes the Generis’s manufacturing facility in Amadora, Portugal which has a capacity to produce 1.2 billion tablets/capsules/sachets annually.Closing of the transaction, however, is conditional on obtaining necessary approvals from the Portuguese authorities.

 
 
 
Our Offerings